期刊文献+

益气活血利水法对心衰大鼠血管加压素-水通道蛋白2系统的影响 被引量:5

Effect of Yiqi Huoxue Lishui Method on Rat of Heart Failure AVP-V2R-AQP2 System
下载PDF
导出
摘要 目的:研究益气活血利水法对于心衰大鼠精氨酸血管加压素-V2受体-水通道蛋白2系统的影响,以探讨本法对心衰水液潴留的作用机制。方法:选择健康Wistar大鼠,应用腹腔注射阿霉素(3 mg/kg,每周1次,连续6周)及睡眠剥夺,造成心衰大鼠模型,然后分空白组、模型组,芪苈强心组、中药高剂量、中剂量、低剂量6组,服药4周后观察6组大鼠服药后血浆精氨酸血管加压素(AVP)浓度;血管加压素V2受体(V2R)、水通道蛋白2(AQP2)蛋白表达情况。结果:益气活血利水法可降低心衰大鼠血浆中升高的AVP浓度,与模型组比较,有统计学差异;可部分减弱肾脏组织V2R、AQP2蛋白表达。结论:益气活血利水法通过降低血浆中AVP浓度,下调V2R、AQP2蛋白表达来作用于精氨酸血管加压素-V2受体-水通道蛋白2系统的每个环节而起到改善水液潴留之目的。 Objective : To study the effect of Yiqi Huoxue Lishui method on the rat of heart failure AVP V2R AQP2 system in order to explore the effect on HF water retention mechanism by means of this method. Methods : Healthy Wistar rats have been cho sen,which have been injected adriamycin through abdominal cavity (3 mg/kg, once a week, succession of 6 weeks) with sleep deprivation to make model of HF rats. Then six groups could be divided : blank, model, Qili Qiangxin, high, medium and low dose Chinese medicine groups. Four weeks later, six groups of rats with medicine could be observed the concentration of plasma AVPwith the method of ELISA, and could be tested the condition of protease of renal organization (spinal cord) V2R, AQP2 with im munohistochemical and western blot methods. Results:Method of Yiqi Huoxue Lishui could reduce concentration of HF rats' high AVP concentration. Compared with group model, statistical difference could be found. The method could also weaken renal organi zation V2R, AQP2 protease;so that the result was better than model group, especially medium and high dose groups. Conclusion: Method of Yiqi Huoxue Lishui reduces the AVP concentration of plasma and V2R, AQP2 protease, to take effect on each section in V2R AOP2 system, and then imvrove water retention.
出处 《辽宁中医杂志》 CAS 2013年第12期2596-2598,共3页 Liaoning Journal of Traditional Chinese Medicine
基金 吉林省卫生厅资助项目(2010-209)
关键词 慢性心力衰竭 益气活血利水法 血管加压素 水通道蛋白2 heart failure Yiqi Huoxue Lishui method Arginine vasopressin Aquaporin 2
  • 相关文献

参考文献6

二级参考文献85

  • 1李一石,华潞,陈君柱,黄德嘉,黄洁,何建国,姚康宝,张健,蒋文,汪芳,苏绮,刘晗,成小如,康健,张阴凤.托拉塞米、呋噻米治疗慢性心力衰竭水肿的疗效和安全性比较研究[J].中国循环杂志,2004,19(4):290-293. 被引量:22
  • 2王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 3李学军,于和鸣.水通道的分子生物学研究[J].生理科学进展,1996,27(1):19-24. 被引量:17
  • 4Braunwald E. Heart disease[M]. Philadelphia: W. B. Saunders Company, 1997: 445.
  • 5邓中甲.方剂学[M].北京:中国中医药出版社,2005.152.
  • 6Chow KM, Szeto CC, Wong TY, et al. Risk factors for thiazide - induced hyponatraemia[ J]. QJM,2003,96(12) :911 -917.
  • 7Sica DA. Diuretic -related side effects: development and treatment[J]. J Clin Hypertens (Greenwich) ,2004,6 (9) :532 - 540.
  • 8Goldsmith SR, Gheorghiade M. Vasopressin antagonism in heart failure[J]. J Am Coil Cardiol, 2005,46(10) :1785 - 1791.
  • 9Hawkins RG, Houston MC. Is population - wide diuretic use directly associated with the incidence of end - stage renal disease in the United States? A hypothesis[J]. Am J Hypertens, 2005, 18(6) :744 -749.
  • 10Akram M, Reddan D. Diuretic use and ESRD, precipitating factor or epiphenomenon[J]. Am J Hypertens,2005,18(6) :739 - 740.

共引文献3895

同被引文献78

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部